Showing results (31-40 of 523) with videos related to
Sort By:
Pageof 53
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|September 22, 2006
Targeting hypertension with valsartan: Lessons learned from the Valsartan/HCTZ versus Amlodipine in stage II hypertensive patients (VASt) trialLuis M Ruilope, Alberto ZanchettiJournal of the American Society of Hypertension : JASH|November 3, 2012
Current status of renal denervation in resistant hypertensionLuis M Ruilope, Roland SchmiederEuropean Journal of Clinical Investigation|March 13, 2012
Are there new threshold and goals in the treatment of arterial hypertension?Julian Segura, Luis M RuilopeFundamental & Clinical Pharmacology|July 14, 2005
Minor abnormalities of renal function: a situation requiring integrated management of cardiovascular riskJulian Segura, Luis M RuilopeAdvances in Chronic Kidney Disease|January 13, 2011
Hypertension in moderate-to-severe nondiabetic CKD patientsJulian Segura, Luis M RuilopeClinical Therapeutics|December 7, 2005
Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertensionLuis M Ruilope, Julian SeguraCurrent Opinion in Nephrology and Hypertension|June 30, 2009
Should diuretics always be included as initial antihypertensive management in early-stage CKD?Julian Segura, Luis M RuilopeExpert Opinion on Pharmacotherapy|October 28, 2010
ARBs and ACEis together in the treatment of hypertension and its complications? current practical recommendationsLuis M Ruilope, Julian SeguraCurrent Hypertension Reports|November 4, 2010
Dual-acting angiotensin receptor-neprilysin inhibitionJulian Segura, Luis M RuilopeEuropean Heart Journal. Cardiovascular Pharmacotherapy|July 16, 2016
Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protectionJavier Díez, Luis M RuilopePageof 53